Skip to main content

Peer Review reports

From: Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial

Original Submission
22 Jun 2021 Submitted Original manuscript
31 Aug 2021 Reviewed Reviewer Report - Ravi Philip Rajkumar
22 Sep 2021 Reviewed Reviewer Report - Luc Mallet
18 Oct 2021 Author responded Author comments - Mohammadreza Shalbafan
Resubmission - Version 2
18 Oct 2021 Submitted Manuscript version 2
26 Oct 2021 Author responded Author comments - Mohammadreza Shalbafan
Resubmission - Version 3
26 Oct 2021 Submitted Manuscript version 3
4 Nov 2021 Author responded Author comments - Mohammadreza Shalbafan
Resubmission - Version 4
4 Nov 2021 Submitted Manuscript version 4
11 Nov 2021 Reviewed Reviewer Report - Ravi Philip Rajkumar
18 Nov 2021 Reviewed Reviewer Report - Luc Mallet
30 Nov 2021 Author responded Author comments - Mohammadreza Shalbafan
Resubmission - Version 5
30 Nov 2021 Submitted Manuscript version 5
Publishing
8 Dec 2021 Editorially accepted
12 Jan 2022 Article published 10.1186/s12888-021-03642-z

You can find further information about peer review here.

Back to article page